Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| CDP-Choline (Citicoline) | Phenylpiracetam | |
|---|---|---|
| Category | Nootropics | Nootropics |
| Standard Dose | 250-500 mg/day | 100-300 mg/day divided into 1-2 doses |
| Timing | Morning or split morning/afternoon. With or without food. | Morning or early afternoon; avoid evening use due to stimulant effects. Take with or without food. |
| Cycle Duration | Ongoing; no cycling required | Use sparingly — tolerance develops rapidly. Best cycled 2 weeks on, 2 weeks off, or reserved for acute-need situations. |
| Evidence Level | strong_human | moderate_human |
Prodrug that is hydrolyzed to choline and cytidine upon oral ingestion. Choline supports acetylcholine synthesis and phosphatidylcholine membrane repair. Cytidine is converted to uridine, which enhances synaptic membrane synthesis via the Kennedy pathway and upregulates dopamine receptor density. This dual mechanism — cholinergic support plus dopaminergic modulation — is unique among choline sources.
250-500 mg/day
Morning or split morning/afternoon. With or without food.
Ongoing; no cycling required
Atypical dopamine reuptake inhibitor with additional phenethylamine-like stimulatory properties. Increases the density of acetylcholine, NMDA, GABA, and dopamine receptors in the brain. The phenyl group addition to the piracetam backbone enables blood-brain barrier penetration at 20-60x greater potency than piracetam, with added psychostimulant and cold-tolerance properties.
100-300 mg/day divided into 1-2 doses
Morning or early afternoon; avoid evening use due to stimulant effects. Take with or without food.
Use sparingly — tolerance develops rapidly. Best cycled 2 weeks on, 2 weeks off, or reserved for acute-need situations.
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →